Advertisement

IOPE MILD CLINIC SUN PROTECTOR | IOPE MILD CLINIC SUN PROTECTOR

17:39 EDT 22nd May 2013 | BioPortfolio
Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

Drug Facts

TITANIUM DIOXIDE 3.7% / ZINC OXIDE 7.55%

Sunscreen

Helps prevent sunburn

For external use only.

Keep out of eyes. Rinse with water to remove.

Rash or irritation develops and lasts

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Apply smoothly before sun exposure and as needed. Children under 6 months of age : ask a doctor

WATER, CYCLOPENTASILOXANE, BUTYLENE GLYCOL, C12-15 ALKYL BENZOATE, DIMETHICONE, PEG-10 DIMETHICONE, GLYCERIN, CYCLOHEXASILOXANE, OCTYLDODECYL MYRISTATE, DICAPRYLYL CARBONATE, PANTHENOL, NIACINAMIDE, CENTELLA ASIATICA EXTRACT, CETEARYL OLIVATE, SORBITAN OLIVATE, 1,2-HEXANEDIOL, SILICA, LAURYL PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE, VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER, POLYMETHYL METHACRYLATE, ALUMINUM STEARATE, POLYSILICONE-11, POLYMETHYLSILSESQUIOXANE, POLYHYDROXYSTEARIC ACID, MAGNESIUM SULFATE, DISTEARDIMONIUM HECTORITE, ALUMINA, TRIETHYL CITRATE, ETHYLHEXYLGLYCERIN, STEARIC ACID, MYRISTIC ACID, DISODIUM EDTA

IOPE

MILD CLINICSUN PROTECTOR

This skin constitution improvement clinic providesin-depth care for internal and external causes of skinproblems. It helps your unbalanced skin become normal and healthier by making it resistant to stress andrestoring skin balance.

SPF 25 PA++

60 ml / 2.0 FL. OZ.

IMAGE iope-01.jpg

Manufacturer

AMOREPACIFIC

Active Ingredients

Source

Drugs and Medications [ 71 Associated Drugs and Medications listed on BioPortfolio]

Iope ss [AMOREPACIFIC]

IOPE SMALL&SMOOTH S.S CONDITIONING TWIN CAKE

Iope ss [AMOREPACIFIC]

IOPE SMALL&SMOOTH S.S CONDITIONING FOUNDATION

Iope retigen moisture twin cake [AMOREPACIFIC]

IOPE RETIGEN MOISTURE TWIN CAKE

Iope s.s. conditioning color base no.40 [AMOREPACIFIC]

IOPE S.S CONDITIONING COLOR BASE[SPF 22/PA+]

Iope retigen moisture foundation [AMOREPACIFIC]

IOPE RETIGEN MOISTURE FOUNDATION [SPF 22/PA+]

Clinical Trials [ 1468 Associated Clinical Trials listed on BioPortfolio]

Hip Protector for Prevention of Hip Fracture

This study aims to evaluate the efficacy of the investigators PSU hip protector for prevention of fracture in elderly.The eligible patients include those with previous diagnosed as unilate...

Pilot Safety Study to Determine the Ability of the Protector Cap Jet Injector to Prevent Cross-Contamination

The primary purpose of this study is to determine the ability of the Protector Cap Jet Injector to prevent cross-contamination in the next injection sample. The hypothesis is that the Pro...

Pain Outcomes Following Video-Assisted Thoracic Surgery (VATS) With LAP Protector

The purpose of this study is to see if different types of spreading (rigid or soft) of Video-assisted Thoracoscopic Surgery (VATS) for lung cancer have different effects on pain.

Study of Two Different 10.0% Benzoyl Peroxide Creams for Mild to Moderate Acne Vulgaris

This study is a split face, paired-comparison, pilot study of 10 subjects. Participants in this study will be patients seen at Children's Memorial Hospital, who are clinically diagnosed wi...

Comparison of Two Basal Insulins for Patients With Type 2 Diabetes on Anti-Hyperglycemic Medications (IOPE)

The purpose of this study is to examine the effectiveness and safety of insulin lispro protamine suspension (ILPS) as compared to insulin glargine as basal insulin therapy in adults with t...

PubMed Articles [ 5699 Associated PubMed Articles listed on BioPortfolio]

Availability and use of hip protectors in residents of nursing homes.

Potential predictors of availability and use of hip protectors were studied in residents of 48 nursing homes. The likelihood of being offered a hip protector was reduced in men, in residents with very...

A prospective, randomized study on the efficacy of tongue protector in patients with burning mouth syndrome.

Oral Diseases (2010) doi: 10.1111/j.1601-0825.2010.01737.x Objective:  To apply a tongue protector with habit-modifying therapy through self-control, in the patients with burning mouth syndrome (BMS...

Nursing staff attitudes of hip protector use in long-term care, and differences in characteristics between adherent and non-adherent residents: A survey and observational study.

BACKGROUND: Hip fractures represent an increasing public health burden with a simple fall to the floor as the most common cause. Because nursing home residents are particularly at risk, nursing homes...

Metastasis: A new protector?

Clinical practice. Mild cognitive impairment.

Search BioPortfolio:
Advertisement

Drugs and Medication Quicklinks


Searches Linking to this Drug Record

Advertisement